Skip to main content

Table 2 Screening for viral hepatitis and hepatitis B vaccinations among individuals aged between 15 and 64 years according to sex and age in Brazil as measured by the in the PCAP-2013

From: State of viral hepatitis knowledge and testing uptake in Brazil: Findings from the National Survey of Knowledge, Attitudes and Practices (PCAP-2013)

   Men Women
Total 15–24 25–49 50–64 All age groups p-value 15–24 25–49 50–64 All age groups p-value
VH screening, ever 29 (27.6–30.4) 14.3 (11.9–17.1) 27.7 (25.6–29.9) 25.5 (22.3–28.9) 23.7 (22.1–25.3) <0.001 24.5 (21.6–27.6) 41 (38.4–43.6) 26.6 (23.8–29.6) 34 (32–36) <0.001
HBV 44.6 (42.2–47.2) 46.2 (37.2–55.5) 47.4 (42.9–52) 39.9 (33–47.3) 45.8 (42–49.6) 0.25 49.4 (42.9–55.9) 43.6 (39.8–47.5) 38.5 (32.5–44.8) 43.9 (40.1–47.2) 0.05
HCV 32 (29.7–34.5) 36.3 (27.6–46.1) 33.5 (29.2–38) 32.8 (26.4–40) 33.8 (30.3–37.6) 0.79 29.3 (23.2–36.4) 31.5 (27.9–35.4) 29.8 (24.1–36.2) 30.8 (27.7–34.1) 0.77
HDV 16.8 (13.7–19) 15.7 (10–23.8) 16.8 (13.8–20.3) 14.5 (10.3–20.1) 16.2 (16.7–19) 0.77 17.6 (12.4–24.3) 16.9 (14.1–20.1) 14.9 (10.8–20.2) 16.7 (14.2–19.6) 0.73
VH screening, last 12 months 36.2 (35.5–42.7) 38.5 (29.7–48) 40 (35.7–44.5) 36.3 (29.5–43.8) 39.1 (35.5–42.7) 0.70 45 (38.4–51.7) 33.2 (29.5–37.1) 26.3 (21–32.3) 34.3 (31.4–37.2) 0.0003
VH screening using rapid testing, ever 17.5 (15.6–19.6) 16.2 (10.1–25.1) 21 (17.3–25.2) 16.3 (11.8–22.2) 19.3 (16.5–22.4) 0.31 24 (18.2–31.1) 14.7 (12.1–17.8) 14.1 (10.1–19.3) 16.3 (13.8–19.2) 0.002
Knowledge of last VH test results 89.9 (88.3–91.3) 84.2 (75.2–90.4) 88.7 (84.7–91.8) 89.9 (84.3–93.7) 88.3 (85.2–90.7) 0.36 89.8 (85.5–93) 91.4 (89–93.3) 90.2 (86.6–93) 90.9 (89–92.5) 0.61
Knowledge of any health service that offers free screening for VH 38.7 (37–40.5) 26 (23–29.2) 34.6 (32.1–37.3) 33.3 (29.9–36.9) 32.1 (30–34.2) <0.001 36 (32.8–40) 50.4 (47.6–53.3) 42.3 (38.9–46) 45.1 (42.7–47.5) <0.001
HBV vaccination (1 dose) 73.9 (72.4–75.4) 68.8 (65.3–72) 71.3 (68.6–73.8) 72.2 (68.8–75.4) 70.8 (68.5–73) 0.19 76.8 (73.9–79.5) 76.4 (74–78.6) 78.6 (75.8–81.2) 76.9 (75–78.8) 0.38
HBV vaccination (3 doses) 18.3 (17.0–19.6) 10.3 (8.4–12.5) 14.3 (12.6–16.3) 12.8 (10.6–15.3) 13.0 (11.6–14.5) 0.01 24.7 (22.0–27.6) 24.6 (22.2–27.2) 17.9 (15.5–20.5) 23.3 (21.3–25.5) <0.001
Denominators
Unweighted 12000 1503 3002 1495 6000 … 1499 3002 1499 6000 …
Weighted 12000 1577 3208 1081 5867 … 1565 3362 1207 6133 …
  1. ... not statistically significant
Back to article page

Hepatology, Medicine and Policy

ISSN: 2059-5166

Contact us